Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant Melanoma  Cynthia Spittle, M. Renee Ward, Katherine.

Slides:



Advertisements
Similar presentations
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Advertisements

A Melting Curve Analysis–Based PCR Assay for One-Step Genotyping of β- Thalassemia Mutations  Fu Xiong, Qiuying Huang, Xiaoyun Chen, Yuqiu Zhou, Xinhua.
Detection of Exon 12 Mutations in the JAK2 Gene
The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer  Irene Mancini,
High-Throughput Homogeneous Mass Cleave Assay Technology for the Diagnosis of Autosomal Recessive Parkinson's Disease  Christopher Schroeder, Michael.
Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes  Ji Eun Oh, Hee Sun.
Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA  Christina Wood-Bouwens, Billy T. Lau, Christine.
A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single- Nucleotide Variant Detection  Chung Lee, Joon S. Bae, Gyu H. Ryu, Nayoung.
High-Throughput, Multiplex Genotyping Directly from Blood or Dried Blood Spot without DNA Extraction for the Screening of Multiple G6PD Gene Variants.
Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Ronald van Marion, Niels M
A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.
Rapid and Simple Detection of Hot Spot Point Mutations of Epidermal Growth Factor Receptor, BRAF, and NRAS in Cancers Using the Loop-Hybrid Mobility Shift.
Kirby Siemering, Shehnaaz S. M. Manji, Wendy M
High-Fidelity DNA Polymerase Enhances the Sensitivity of a Peptide Nucleic Acid Clamp PCR Assay for K-ras Mutations  Bjørnar Gilje, Reino Heikkilä, Satu.
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.
A Melting Curve Analysis–Based PCR Assay for One-Step Genotyping of β- Thalassemia Mutations  Fu Xiong, Qiuying Huang, Xiaoyun Chen, Yuqiu Zhou, Xinhua.
Gene Dysregulations Driven by Somatic Copy Number Aberrations-Biological and Clinical Implications in Colon Tumors  Manny D. Bacolod, Francis Barany 
Philippe Szankasi, Mohamed Jama, David W. Bahler 
Single Nucleotide Polymorphism-Based System Improves the Applicability of Quantitative PCR for Chimerism Monitoring  Egle Gineikiene, Mindaugas Stoskus,
A High-Resolution Melting Protocol for Rapid and Accurate Differential Diagnosis of Thyroid Nodules  Irene Mancini, Pamela Pinzani, Cinzia Pupilli, Luisa.
Development and Applications of a BRAF Oligonucleotide Microarray
Comparison of Allelic Discrimination by dHPLC, HRM, and TaqMan in the Detection of BRAF Mutation V600E  Pablo Carbonell, María C. Turpin, Daniel Torres-Moreno,
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
Evaluation of the Cepheid GeneXpert BCR-ABL Assay
Nucleotide Extension Genotyping by High-Resolution Melting
Multiplex Pyrosequencing of Two Polymorphisms in DNA Repair Gene XRCC1
Ken B. Waites, Li Xiao, Vanya Paralanov, Rose M. Viscardi, John I
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Molly Yancovitz, Joanne Yoon, Maryann Mikhail, Weiming Gai, Richard L
Detection of KRAS and BRAF Mutations in Colorectal Carcinoma
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Shaoyu Zhou, Keyaunoosh Kassauei, David J. Cutler, Giulia C
Christine L. Baker, Cecily P. Vaughn, Wade S. Samowitz 
Rapid Screening Assay for KRAS Mutations by the Modified Smart Amplification Process  Kenji Tatsumi, Yasumasa Mitani, Jun Watanabe, Hideki Takakura, Kanako.
Quantitative Determination of JAK2 V617F by TaqMan
Multiplex Ligation-Dependent Probe Amplification Versus Multiprobe Fluorescence in Situ Hybridization To Detect Genomic Aberrations in Chronic Lymphocytic.
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Detection of Exon 12 Mutations in the JAK2 Gene
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
Evaluation of BRAF Mutation Testing Methodologies in Formalin-Fixed, Paraffin- Embedded Cutaneous Melanomas  Johanne Lade-Keller, Kirsten M. Rømer, Per.
Genotyping of Frequent BRCA1/2 SNPs with Unlabeled Probes
Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis.
KRAS Mutation The Journal of Molecular Diagnostics
BRAF Mutation Testing in Solid Tumors
Absence of the Caveolin-1 P132L Mutation in Cancers of the Breast and Other Organs  Shinya Koike, Yasuhiro Kodera, Akimasa Nakao, Hiroji Iwata, Yasushi.
Development of a Quantitative Real-Time Polymerase Chain Reaction Assay for the Detection of the JAK2 V617F Mutation  Elizabeth C. Wolstencroft, Katy.
Ashleigh C. McEvoy, Benjamin A. Wood, Nima M. Ardakani, Michelle R
A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations  Bárbara Angulo, Elena García-García, Rebeca.
Detection of BRAF V600E Mutation in Colorectal Cancer
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Accurate Detection of Copy Number Changes in DNA Extracted from Formalin-Fixed, Paraffin-Embedded Melanoma Tissue Using Duplex Ratio Tests  David A. Moore,
Simultaneous Amplification, Detection, and Analysis of Common Mutations in the Galactose-1-Phosphate Uridyl Transferase Gene  Mohamed Jama, Lesa Nelson,
Performance and Clinical Evaluation of a Sensitive Multiplex Assay for the Rapid Detection of Common NPM1 Mutations  Michael Hafez, Fei Ye, Keith Jackson,
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Low Incidence of Minor BRAF V600 Mutation-Positive Subclones in Primary and Metastatic Melanoma Determined by Sensitive and Quantitative Real-Time PCR 
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Gene Dysregulations Driven by Somatic Copy Number Aberrations-Biological and Clinical Implications in Colon Tumors  Manny D. Bacolod, Francis Barany 
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing  Liying Zhang, Tomas Kirchhoff, Cindy.
A Pyrosequencing-Based Assay for the Rapid Detection of the 22q11
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Novel Method for PIK3CA Mutation Analysis
Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas  Qiulu Pan, William Pao, Marc.
Improved Detection of KIT Exon 11 Duplications in Formalin-Fixed, Paraffin-Embedded Gastrointestinal Stromal Tumors  Jerzy Lasota, Bartosz Wasag, Sonja.
Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors  Martin Pichler, Marija Balic,
Steven F. Dobrowolski, Richard A. Banas, Joseph G
Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations  Athanasios C. Tsiatis, Alexis Norris-Kirby,
KIT Gene Deletions at the Intron 10−Exon 11 Boundary in GI Stromal Tumors  Christopher L. Corless, Laura McGreevey, Ajia Town, Arin Schroeder, Troy Bainbridge,
Detection of BRCA1 and BRCA2 Ashkenazi Jewish Founder Mutations in Formalin- Fixed Paraffin-Embedded Tissues Using Conventional PCR and Heteroduplex/Amplicon.
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification 
Presentation transcript:

Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant Melanoma  Cynthia Spittle, M. Renee Ward, Katherine L. Nathanson, Phyllis A. Gimotty, Eric Rappaport, Marcia S. Brose, Angelica Medina, Richard Letrero, Meenhard Herlyn, Robin H. Edwards  The Journal of Molecular Diagnostics  Volume 9, Issue 4, Pages 464-471 (September 2007) DOI: 10.2353/jmoldx.2007.060191 Copyright © 2007 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 1 Detection of V600E in melanoma cell lines. Pyrograms generated for BRAF wild-type (WM3208) (A), heterozygous mutant (WM 902B) (B), and homozygous mutant (WM39) (C) cell lines distinguish T versus A peaks (yellow shading). Nucleotide dispensation order is given below each pyrogram. Numerical position for each nucleotide is indicated at the top. Dispensations of C at positions 1 and 6 are included as controls for misincorporation. Dideoxy cycle sequence tracings for each cell line are shown for comparison. The Journal of Molecular Diagnostics 2007 9, 464-471DOI: (10.2353/jmoldx.2007.060191) Copyright © 2007 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 2 Detection of BRAF variant mutations. Pyrograms for two variant mutations, V600R (B) and V600K (C), show distinct patterns compared with V600E (A). Changes in relative A/G peak heights at pyrogram positions 2, 3, 5, 7, and/or 8 reflect dinucleotide substitutions given at right. The specific variants are confirmed by dideoxy cycle sequencing. The Journal of Molecular Diagnostics 2007 9, 464-471DOI: (10.2353/jmoldx.2007.060191) Copyright © 2007 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 3 Applicability of pyrosequencing assay to FFPE tissue. Pyrograms generated from a V600E mutant tumor (A) and a V600K mutant tumor (B) are identical for paired frozen and FFPE tumors. The Journal of Molecular Diagnostics 2007 9, 464-471DOI: (10.2353/jmoldx.2007.060191) Copyright © 2007 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 4 Cell line DNA mixing study. Theoretical peak heights, calculated from initial percent mutant A peak in undiluted heterozygous V600E mutant tumor, are correlated with actual peak heights generated for each dilution (Pearson's correlation = 0.96), indicating a linear relationship. The Journal of Molecular Diagnostics 2007 9, 464-471DOI: (10.2353/jmoldx.2007.060191) Copyright © 2007 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 5 Analytic sensitivity for V600E detection in a heterozygous tumor. Pyrograms generated from dilution series for two separate experiments (day 1 and day 2) are shown with corresponding dideoxy sequence tracings for day 1 data. The percent tumor corresponding to each data set is indicated at left. The Journal of Molecular Diagnostics 2007 9, 464-471DOI: (10.2353/jmoldx.2007.060191) Copyright © 2007 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 6 Comparison of pyrosequencing data with SNP microarrays. A: SNP XbaI 50K microarray data for chromosome 7 displayed with CNAT 3.0 software. Melanoma cell lines analyzed and location of BRAF gene are indicated. For each cell line, genome smoothed chromosome copy number data are shown at the top and the LOH score is shown at the bottom. Chromosome location in megabases is given at the bottom of the data set for each cell line. Scale for copy number and LOH score indicated at right. B: Corresponding BRAF pyrosequencing data including percent T and A peaks are indicated for each cell line. The Journal of Molecular Diagnostics 2007 9, 464-471DOI: (10.2353/jmoldx.2007.060191) Copyright © 2007 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions